Association of Appropriate Empirical Antimicrobial Therapy With In-Hospital Mortality in Patients With Bloodstream Infections in the US

  05 January 2023

Is the use of appropriate initial empirical antimicrobial therapy associated with lower in-hospital mortality in patients with bloodstream infections?

In this cross-sectional study including 32 100 patients with bloodstream infections from 183 US hospitals, the crude proportions of appropriate empirical therapy use were 94.4% for gram-negative rods, 97.0% for gram-positive cocci, and 65.1% for Candida species, with lower proportions for resistant pathogens. Receipt of appropriate empirical antimicrobial therapy was associated with lower in-hospital mortality for patients infected with gram-negative rods, gram-positive cocci, and Candida species.

This study suggests that use of appropriate initial empirical antimicrobial therapy may have a role in inpatient hospital mortality.

Further reading: JAMA Network
Author(s): Tetsu Ohnuma et al
Healthy Patients  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!